Trials / Completed
CompletedNCT00736801
Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- University of Rostock · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
BDNF has been linked to the pathogenesis of airway hyperresponsiveness in asthma. In this trial, the impact of a treatment with salmeterol and salmeterol / fluticasone on BDNF concentrations will be assessed in patients with asthma. The investigators hypothesize that salmeterol impacts on BDNF concentrations in patients with asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol and Salmeterol / Fluticasone | Patients inhale salmeterol for 2 weeks, followed by an inhalation of both salmeterol and fluticasone for 2 weeks. |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-01-01
- Completion
- 2007-04-01
- First posted
- 2008-08-18
- Last updated
- 2008-08-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00736801. Inclusion in this directory is not an endorsement.